FineMark National Bank & Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-556
| Closed | -$309K | – | 441 |
|
2023
Q4 | $309K | Sell |
556
-224
| -29% | -$124K | 0.01% | 330 |
|
2023
Q3 | $341K | Buy |
780
+200
| +34% | +$87.5K | 0.01% | 312 |
|
2023
Q2 | $291K | Sell |
580
-36
| -6% | -$18.1K | 0.01% | 350 |
|
2023
Q1 | $308K | Buy |
616
+71
| +13% | +$35.5K | 0.01% | 333 |
|
2022
Q4 | $222K | Buy |
+545
| New | +$222K | 0.01% | 366 |
|
2022
Q2 | – | Sell |
-545
| Closed | -$298K | – | 432 |
|
2022
Q1 | $298K | Sell |
545
-90
| -14% | -$49.2K | 0.01% | 366 |
|
2021
Q4 | $418K | Sell |
635
-2
| -0.3% | -$1.32K | 0.02% | 325 |
|
2021
Q3 | $396K | Buy |
637
+2
| +0.3% | +$1.24K | 0.02% | 315 |
|
2021
Q2 | $401K | Hold |
635
| – | – | 0.02% | 324 |
|
2021
Q1 | $311K | Buy |
635
+90
| +17% | +$44.1K | 0.01% | 346 |
|
2020
Q4 | $272K | Sell |
545
-15
| -3% | -$7.49K | 0.01% | 350 |
|
2020
Q3 | $220K | Buy |
+560
| New | +$220K | 0.01% | 353 |
|
2017
Q1 | – | Sell |
-340
| Closed | -$40K | – | 659 |
|
2016
Q4 | $40K | Sell |
340
-80
| -19% | -$9.41K | ﹤0.01% | 674 |
|
2016
Q3 | $47K | Hold |
420
| – | – | 0.01% | 623 |
|
2016
Q2 | $39K | Sell |
420
-345
| -45% | -$32K | ﹤0.01% | 660 |
|
2016
Q1 | $60K | Sell |
765
-12
| -2% | -$941 | 0.01% | 532 |
|
2015
Q4 | $57K | Sell |
777
-134
| -15% | -$9.83K | 0.01% | 568 |
|
2015
Q3 | $67K | Buy |
911
+213
| +31% | +$15.7K | 0.01% | 546 |
|
2015
Q2 | $45K | Sell |
698
-188
| -21% | -$12.1K | 0.01% | 681 |
|
2015
Q1 | $68K | Buy |
886
+18
| +2% | +$1.38K | 0.01% | 582 |
|
2014
Q4 | $64K | Buy |
+868
| New | +$64K | 0.01% | 593 |
|